Well, it wasn't a good quarterly! As suggested, Nd/Pr production fell for the quarter. Total production fell for the quarter. The ASP fell for the quarter. Sales volume was up 15% but revenue only 7.5%, so in spite of higher prices for the Nd/Pr the prices for La/Ce must have fallen substantially.
It being a not good result isn't a reflection on management's efforts, it's symptomatic of the market conditions.
Why are you sounding off at me? Here is the post that got it totally wrong:
"What a load of crap. How on earth would you be certain. Not being a cash cashflow positive is against the market expectation and the progress that has been made over the past few quarters. Being cashflow negative is a material-sensitive information and the company is legally bound to inform ASX and the market." #16739318
Once again, sydney accuses Lynas management of acting illegally. As well as being completely wrong.
- Forums
- ASX - By Stock
- LYC
- Ann: Quarterly Activities Report
LYC
lynas rare earths limited
Add to My Watchlist
1.50%
!
$10.15

Ann: Quarterly Activities Report, page-39
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.15 |
Change
0.150(1.50%) |
Mkt cap ! $9.494B |
Open | High | Low | Value | Volume |
$10.25 | $10.32 | $10.00 | $19.17M | 1.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 12155 | $10.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.15 | 6724 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 6956 | 10.140 |
19 | 8810 | 10.130 |
15 | 11305 | 10.120 |
16 | 9233 | 10.110 |
11 | 115163 | 10.100 |
Price($) | Vol. | No. |
---|---|---|
10.150 | 5703 | 13 |
10.160 | 11682 | 29 |
10.170 | 18395 | 10 |
10.180 | 17438 | 13 |
10.190 | 13113 | 11 |
Last trade - 12.00pm 15/07/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online